News

Apply to Attend a Combination Therapies for Cancer Treatment Micro Lab In September

Combination therapies are the cornerstone of cancer treatment. Are you involved in treating cancer patients, researching the biology underlying cancer, or investigating new medications or drug combinations?

If so, consider attending one, two, or all four focused discussions (“micro labs”) co-hosted this September by NCI’s Division of Cancer Biology and IBM Research. The Combination Therapies for Cancer Treatment Micro Labs will bring together experts in cancer biology and treatment to address the biological complexity at the core of combination therapy interventions, with the goal of improving cancer patient outcomes.

Micro Labs Dates and Descriptions*

*All micro labs are scheduled from 11:00 a.m.–2:00 p.m. ET.